TREATMENT OF MILD TRAUMATIC BRAIN INJURY - OXEIA BIOPHARMACEUTICALS INC

Title:

TREATMENT OF MILD TRAUMATIC BRAIN INJURY

Document Type and Number:

WIPO Patent Application WO/2024/054875

Kind Code:

A3

Abstract:

Disclosed are methods for mitigating one or more debilitating symptoms of a mTBI for a patient diagnosed with mTBI, e.g. sustained mTBI. These methods comprise administering an effective amount of ghrelin or a variant thereof over multiple consecutive days after the diagnosis of a mTBI, e.g. sustained mTBI.

Inventors:

BANSAL VISHAL (US)
SHAH KARTIK (US)
WYAND MICHAEL (US)

Application Number:

PCT/US2023/073587

Publication Date:

April 11, 2024

Filing Date:

September 06, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

OXEIA BIOPHARMACEUTICALS INC (US)

International Classes:

A61K38/22; A61B5/16; A61K38/16; A61P25/00

Attorney, Agent or Firm:

MASSEY, Cory A. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: USE OF IL-2R-BETA-GAMMA AGONIST PEPTIDES IN CELL MANUFACTURING

Next Patent: LEUCINE RICH REPEAT KINASE 2 (LRRK2) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE